Secretin synthetic porcine - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for secretin synthetic porcine and what is the scope of freedom to operate?
Secretin synthetic porcine
is the generic ingredient in one branded drug marketed by Chirhoclin and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for secretin synthetic porcine
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 11 |
| Clinical Trials: | 4 |
| Patent Applications: | 192 |
| DailyMed Link: | secretin synthetic porcine at DailyMed |
Recent Clinical Trials for secretin synthetic porcine
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Massachusetts General Hospital | Phase 1 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Phase 3 |
| National Institute on Deafness and Other Communication Disorders (NIDCD) | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for secretin synthetic porcine
US Patents and Regulatory Information for secretin synthetic porcine
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chirhoclin | SECREFLO | secretin synthetic porcine | FOR SOLUTION;INTRAVENOUS | 021136-001 | Apr 4, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
